250 related articles for article (PubMed ID: 22387278)
1. Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice.
Ragelle H; Crauste-Manciet S; Seguin J; Brossard D; Scherman D; Arnaud P; Chabot GG
Int J Pharm; 2012 May; 427(2):452-9. PubMed ID: 22387278
[TBL] [Abstract][Full Text] [Related]
2. Liposomal encapsulation of the natural flavonoid fisetin improves bioavailability and antitumor efficacy.
Seguin J; Brullé L; Boyer R; Lu YM; Ramos Romano M; Touil YS; Scherman D; Bessodes M; Mignet N; Chabot GG
Int J Pharm; 2013 Feb; 444(1-2):146-54. PubMed ID: 23380621
[TBL] [Abstract][Full Text] [Related]
3. Highly efficient and lowly toxic docetaxel nanoemulsions for intravenous injection to animals.
Li X; Du L; Wang C; Liu Y; Mei X; Jin Y
Pharmazie; 2011 Jul; 66(7):479-83. PubMed ID: 21812321
[TBL] [Abstract][Full Text] [Related]
4. Development of a liposomal formulation of the natural flavonoid fisetin.
Mignet N; Seguin J; Ramos Romano M; Brullé L; Touil YS; Scherman D; Bessodes M; Chabot GG
Int J Pharm; 2012 Feb; 423(1):69-76. PubMed ID: 21571054
[TBL] [Abstract][Full Text] [Related]
5. Development and bioavailability assessment of ramipril nanoemulsion formulation.
Shafiq S; Shakeel F; Talegaonkar S; Ahmad FJ; Khar RK; Ali M
Eur J Pharm Biopharm; 2007 May; 66(2):227-43. PubMed ID: 17127045
[TBL] [Abstract][Full Text] [Related]
6. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
[TBL] [Abstract][Full Text] [Related]
7. Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform.
Choudhury H; Gorain B; Karmakar S; Biswas E; Dey G; Barik R; Mandal M; Pal TK
Int J Pharm; 2014 Jan; 460(1-2):131-43. PubMed ID: 24239580
[TBL] [Abstract][Full Text] [Related]
8. Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan.
Rajpoot P; Bali V; Pathak K
Int J Pharm; 2012 Apr; 426(1-2):219-230. PubMed ID: 22301424
[TBL] [Abstract][Full Text] [Related]
9. Novel nanoemulsion for minimizing variations in bioavailability of ezetimibe.
Bali V; Ali M; Ali J
J Drug Target; 2010 Aug; 18(7):506-19. PubMed ID: 20067438
[TBL] [Abstract][Full Text] [Related]
10. Improved antiangiogenic and antitumour activity of the combination of the natural flavonoid fisetin and cyclophosphamide in Lewis lung carcinoma-bearing mice.
Touil YS; Seguin J; Scherman D; Chabot GG
Cancer Chemother Pharmacol; 2011 Aug; 68(2):445-55. PubMed ID: 21069336
[TBL] [Abstract][Full Text] [Related]
11. Oil based nanocarrier for improved oral delivery of silymarin: In vitro and in vivo studies.
Parveen R; Baboota S; Ali J; Ahuja A; Vasudev SS; Ahmad S
Int J Pharm; 2011 Jul; 413(1-2):245-53. PubMed ID: 21549187
[TBL] [Abstract][Full Text] [Related]
12. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe.
Bali V; Ali M; Ali J
Colloids Surf B Biointerfaces; 2010 Apr; 76(2):410-20. PubMed ID: 20042320
[TBL] [Abstract][Full Text] [Related]
13. Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis.
Nornoo AO; Osborne DW; Chow DS
Int J Pharm; 2008 Feb; 349(1-2):108-16. PubMed ID: 17869459
[TBL] [Abstract][Full Text] [Related]
14. Effect of process parameters on nanoemulsion droplet size and distribution in SPG membrane emulsification.
Oh DH; Balakrishnan P; Oh YK; Kim DD; Yong CS; Choi HG
Int J Pharm; 2011 Feb; 404(1-2):191-7. PubMed ID: 21055456
[TBL] [Abstract][Full Text] [Related]
15. Cremophor-free intravenous microemulsions for paclitaxel II. Stability, in vitro release and pharmacokinetics.
Nornoo AO; Chow DS
Int J Pharm; 2008 Feb; 349(1-2):117-23. PubMed ID: 17869458
[TBL] [Abstract][Full Text] [Related]
16. Fisetin disposition and metabolism in mice: Identification of geraldol as an active metabolite.
Touil YS; Auzeil N; Boulinguez F; Saighi H; Regazzetti A; Scherman D; Chabot GG
Biochem Pharmacol; 2011 Dec; 82(11):1731-9. PubMed ID: 21840301
[TBL] [Abstract][Full Text] [Related]
17. Self-nanoemulsifying drug delivery system of persimmon leaf extract: Optimization and bioavailability studies.
Li W; Yi S; Wang Z; Chen S; Xin S; Xie J; Zhao C
Int J Pharm; 2011 Nov; 420(1):161-71. PubMed ID: 21884770
[TBL] [Abstract][Full Text] [Related]
18. Nanocarrier for the enhanced bioavailability of a cardiovascular agent: in vitro, pharmacodynamic, pharmacokinetic and stability assessment.
Bali V; Ali M; Ali J
Int J Pharm; 2011 Jan; 403(1-2):46-56. PubMed ID: 20969935
[TBL] [Abstract][Full Text] [Related]
19. Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson's disease by reducing oxidative stress.
Pangeni R; Sharma S; Mustafa G; Ali J; Baboota S
Nanotechnology; 2014 Dec; 25(48):485102. PubMed ID: 25392203
[TBL] [Abstract][Full Text] [Related]
20. Effect of high-pressure homogenization on formulation of TPGS loaded nanoemulsion of rutin - pharmacodynamic and antioxidant studies.
Sharma S; Sahni JK; Ali J; Baboota S
Drug Deliv; 2015; 22(4):541-51. PubMed ID: 24625264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
